QGEN Competitors & Alternatives
Compare QIAGEN N.V. with similar stocks in the same industry
Biological Products, (No Diagnostic Substances)
QGEN
Main Stock$40.38
Tradestie Score
63
Market Cap
$10.04B
P/E Ratio
19.6
Revenue Growth
0.0%
Analyst Upside
+37.4%
Top Competitors
170 stocks in Biological Products, (No Diagnostic Substances)| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AMGN
Amgen Inc
|
$353.28
|
$160.70B | 24.8 | 61 | Compare |
|
GILD
Gilead Sciences Inc
|
$140.30
|
$137.92B | 20.6 | 54 | Compare |
|
ARGX
argenx SE American Depositary Shares
|
$743.12
|
$46.96B | 37.3 | 55 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$89.42
|
$24.57B | - | 56 | Compare |
|
BIIB
Biogen Inc. Common Stock
|
$183.78
|
$22.61B | 20.8 | 57 | Compare |
|
NBIX
Neurocrine Biosciences Inc
|
$132.56
|
$13.59B | 28.2 | 65 | Compare |
|
EXEL
Exelixis Inc
|
$44.04
|
$11.09B | 15.8 | 64 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$50.03
|
$10.74B | - | 56 | Compare |
|
TECH
Bio-Techne Corp.
|
$53.48
|
$9.33B | 98.6 | 62 | Compare |
|
HALO
Halozyme Therapeutics, Inc.
|
$65.40
|
$8.77B | 25.2 | 67 | Compare |
More QGEN Analysis
Data updated: Apr 02, 2026 | Industry: Biological Products, (No Diagnostic Substances) (SIC 2836)
170 stocks in this industry